MEDirect Latino is a rapidly growing, uniquely positioned provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community in the United States and Puerto Rico. MEDirect is the only company positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. The Company's current focus is the distribution of products for the treatment of Type II diabetes specifically because of its disproportionate impact and increasing diagnosis rate within the US Hispanic population, noting an incidence of 120% higher than among non-Hispanic whites. Type II diabetes was also targeted because of its unique status within the Medicare reimbursement regime and because of its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These other conditions represent considerable future market potential that will allow MEDirect to efficiently scale its model by leveraging its existing client base and infrastructure.

The current Hispanic market for MEDirect's products is conservatively estimated at approximately $650MM in the continental United States. The size of the opportunity is understated by such figures as an estimated 925,000 of the over 3.1 million Hispanics in the United States over 65 eligible to receive Medicare benefits are currently collecting these benefits with an estimate that over 1.4 million of those Medicare-eligible Hispanics have diabetes (implying a potential continental U.S. market for MEDirect products of approximately $1 billion).


Click the following links to access financial reports:

•WSR Updated Analytical Profile dated 9/22/05

•WSR Initial Analytical Profile dated 5/16/05

•Knobias IR Profile Page including quotes, news, events, corporate profile, technical data and historical statistics.

Other Financial Information:

15c2-11 Information & Disclosure Statement (for the period ending 04/29/2005)
May 2 2005 ET
Attorney Tradability Letter (for the period ending 04/12/2005)
Apr 28 2005 ET
Quarterly Report (for the period ending 03/31/2005)
Jul 19 2005 ET
Unaudited Financial Statements as of 12/31/04 (for the period ending 12/31/2004)
May 2 2005 ET
Financial Statements for FYE 06/30/03 & 06/30/04 (for the period ending 06/30/2004)
May 2 2005 ET